Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
COVID-19 Patient Resource Center
Clinical Trial Listings
What is Clinical Research?
Volunteering for a Clinical Trial
Understanding Informed Consent
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
eCFR and Guidances
White Papers
Clinical Trial Listings
Advertise
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
» Authors
Featured Authors
Jason Scott
Articles
Authors
(sorted by last name)
A
B
C
D
F
G
H
I
J
K
L
M
P
Q
R
S
T
W
Z
A
Jeffrey Adelglass
Stephanie Akers
B
Joeth Barlas
Michael Bassett
Martin Berman-Gorvine
Christophe Berthoux
Barbara Bolten
Zack Budryk
Daphne Butas
C
Cindy Carter
Elisa Cascade
Lisa Catanese
Lisa Chontos
Declan Conroy
Guest Contributor
Sue Coons
D
Dawn Daugherty
F
Marilyn Fenichel
G
Ken Getz
Amy Ghelardi
Donna Gorman
Paul Gualdoni
H
Conor Hale
Ashley Hay
Amanda Healan
Stephanie Hill
Matthew Howes
I
Mike Ingram
J
Jill Johnston
K
Mary King
Karyn Korieth
L
Susan Muhr Leister
M
Brandon May
Lindsay McNair, M.D.
James Miessler
John Mitchell
Craig Morgan
William Myers
P
Brittany Parker
Charlie Passut
Wayne Pines
Q
Julie Quinn
R
Leslie Ramsey
Sara Ray
Suz Redfearn
Kathy Rembisz
Ronald Rosenberg
S
Susan Salome
Sony Salzman
Tamra Sami
Sandra Sather MS, BSN
Tricia See
Gienna Shaw
CenterWatch Staff
Bill Stedman
Amanda Steenbergen
Colin Stoecker
Michele G. Sullivan
Magdalena Szalowski
T
Elizabeth Tilley Hinkle
Ashley Tointon
W
Elizabeth Weeks Rowe
Michael Whalen
Z
Jeremy Zucker
Gail Zyla
Back to Top
Upcoming Events
06
Jun
Gene & Cell Therapy Regulation: Comparability and Other New Developments
07
Jun
Developing World-Class SOPs: Optimizing Quality and Compliance
08
Jun
Implementing ICH E8 R1 Recommendations Increases Site and Participant Relationship Scoring Measures
Featured Products
Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Featured Stories
MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials
Phase 3 Trials Significantly Rising in Complexity, Says CSDD
Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director
Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here
